Kingworld Medicines Group Limited (HKG:1110)
Hong Kong · Delayed Price · Currency is HKD
0.4750
0.00 (0.00%)
May 12, 2026, 3:59 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices - PRC | 259.06M | 248.28M | 240.94M | 268.77M | 319.96M | | | | | |
Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices - PRC Growth | 4.35% | 3.05% | -10.36% | -16.00% | -13.59% | | | | | |
Distribution Sales of Pharmaceutical and Healthcare Products - Hong Kong | 15.22M | 21.32M | 55.24M | 56.93M | 46.01M | | | | | |
Distribution Sales of Pharmaceutical and Healthcare Products - Hong Kong Growth | -28.58% | -61.41% | -2.97% | 23.74% | -1.03% | | | | | |
Distribution Sales of Pharmaceutical and Healthcare Products - PRC | 753.35M | 919.16M | 899.85M | 734.63M | 563.12M | | | | | |
Distribution Sales of Pharmaceutical and Healthcare Products - PRC Growth | -18.04% | 2.15% | 22.49% | 30.46% | 34.21% | | | | | |
| -2.48M | -4.75M | -1.83M | -8.99M | -7.30M | | | | | |
Elimination of Group's Share of Revenue of Joint Venture | -107.82M | -122.91M | -115.54M | -93.65M | -74.40M | | | | | |
| 917.34M | 1.06B | 1.08B | 957.70M | 847.39M | | | | | |
| -13.55% | -1.63% | 12.63% | 13.02% | 13.68% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
PRC (Excluding Hong Kong) | 656.06M | 808.95M | 808.63M | 667.61M | 514.21M | | | | | |
PRC (Excluding Hong Kong) Growth | -18.90% | 0.04% | 21.12% | 29.83% | 47.03% | | | | | |
| 16.99M | 15.28M | 43.43M | 36.23M | 21.11M | | | | | |
| 11.14% | -64.81% | 19.89% | 71.62% | -38.71% | | | | | |
The United States of America | 100.96M | 108.99M | 108.24M | 124.33M | 184.32M | | | | | |
The United States of America Growth | -7.36% | 0.69% | -12.94% | -32.55% | -29.81% | | | | | |
| 1.03M | 8.97M | 17.89M | 18.25M | 21.29M | | | | | |
The United Kingdom Growth | -88.48% | -49.86% | -1.95% | -14.31% | 23.38% | | | | | |
| 20.15M | 12.41M | - | - | - | | | | | |
| 62.35% | - | - | - | - | | | | | |
| 29.90M | 42.73M | 36.66M | 31.72M | 43.19M | | | | | |
| -30.02% | 16.56% | 15.56% | -26.56% | 22.93% | | | | | |
| 27.00M | 26.18M | 21.23M | 28.13M | 18.41M | | | | | |
| 3.14% | 23.30% | -24.54% | 52.80% | 6.68% | | | | | |
| 3.50M | 2.65M | 1.39M | 1.98M | 3.74M | | | | | |
| 31.76% | 91.62% | -30.12% | -46.99% | - | | | | | |
| 10.30M | 7.83M | 6.73M | 7.40M | 3.08M | | | | | |
| 31.49% | 16.34% | -9.03% | 140.57% | - | | | | | |
| 51.46M | 27.10M | 34.46M | 42.06M | 38.05M | | | | | |
| 89.92% | -21.37% | -18.06% | 10.55% | 31.45% | | | | | |
| 917.34M | 1.06B | 1.08B | 957.70M | 847.39M | | | | | |
| -13.55% | -1.63% | 12.63% | 13.02% | 13.68% | | | | | |
Source: S&P Global Market Intelligence.
